Bender J G, Lum L, Unverzagt K L, Lee W, Van Epps D, George S, Coon J, Ghalie R, McLeod B, Kaizer H
Immunotherapy Division, Baxter Healthcare Corporation, Round Lake, IL 60073.
Bone Marrow Transplant. 1994 Apr;13(4):479-85.
Peripheral blood progenitor cell (PBPC) populations used for transplantation were analyzed for the presence of CD34+ cells, colony-forming cells (initial CFC), and long-term culture initiating cells (LTC-IC) cultured on irradiated stroma for 5 weeks. Thirty-eight leukapheresis products were studied from 11 patients with breast cancer, 2 with non-Hodgkin's lymphoma and 1 with ovarian cancer harvested during recovery from either cyclophosphamide (CY) chemotherapy or cyclophosphamide-VP16 with G-CSF (CY-VP-G). CY-VP-G products had a threefold higher median number of mononuclear cells collected, a fivefold higher median concentration of CD34 and LTC-IC and a threefold higher concentration of initial-CFC when compared with CY products. CY-VP-G products had a significantly higher ratio of CFU-GM to BFU-E than the CY-mobilized products. Significant correlations of r = 0.89 and r = 0.68 were observed when comparing CD34 and CFC in products from CY or CY-VP-G patients, respectively. Analysis of the regression lines indicated that slopes of these regression lines were significantly different with a ratio of CD34 to initial CFC of 15:1 in the CY-VP-G products versus 5.2:1 with the CY products. These data indicate a higher cloning efficiency of the CD34+ population in the products from CY-mobilized patients. Significant correlations of r = 0.9 (CY) and r = 0.53 (CY-VP-G) were observed when the initial CD34 concentration and the LTC-IC were compared. Comparison of initial CFC with LTC-IC also showed significant correlations (r = 0.94, CY; r = 0.58, CY-VP-G) in samples from both patient groups.(ABSTRACT TRUNCATED AT 250 WORDS)
对用于移植的外周血祖细胞(PBPC)群体进行分析,检测其中CD34+细胞、集落形成细胞(初始CFC)以及在经辐照的基质上培养5周的长期培养起始细胞(LTC-IC)的存在情况。研究了11例乳腺癌患者、2例非霍奇金淋巴瘤患者和1例卵巢癌患者的38份白细胞分离产物,这些患者均在接受环磷酰胺(CY)化疗或环磷酰胺-VP16联合G-CSF(CY-VP-G)治疗后恢复期间采集样本。与CY产物相比,CY-VP-G产物采集的单个核细胞中位数数量高出三倍,CD34和LTC-IC的中位数浓度高出五倍,初始CFC浓度高出三倍。CY-VP-G产物中CFU-GM与BFU-E的比例显著高于CY动员的产物。分别比较CY或CY-VP-G患者产物中的CD34和CFC时,观察到显著相关性,r值分别为0.89和0.68。回归线分析表明,这些回归线的斜率存在显著差异,CY-VP-G产物中CD34与初始CFC的比例为15:1,而CY产物为5.2:1。这些数据表明,CY动员患者产物中CD34+群体的克隆效率更高。比较初始CD34浓度和LTC-IC时,观察到显著相关性,CY组r值为0.9,CY-VP-G组r值为0.53。比较两个患者组样本中的初始CFC与LTC-IC时也显示出显著相关性(CY组r = 0.94;CY-VP-G组r = 0.58)。(摘要截选至250字)